The global antipsychotic drugs market is anticipated to grow at a significant CAGR during the forecast period. Antipsychotic drugs are medications used to treat psychological disorders such as schizophrenia and bipolar disorder. Psychosis is a critical symptom that occurs due to mental illness, including loss with reality affecting how one processes information. Though, on contrary to the general perception, the possibility of men and women being affected by bipolar disorder is similar. Thus, the surge in the cases of the disease among females as well as males coupled with the rising need to manage the disease effectively is projected to lead to the demand for these drugs, thereby augmenting the growth of the global antipsychotic drugs market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/antipsychotic-drugs-market
With the shifting perspective of the global population toward mental health, there is an increased demand for diagnosis and treatment of various mental disorders. Bipolar disorder, being one such prevalent issue, which is anticipated to spur its drugs market. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the prevalence of bipolar disorder across the world varies from 0.3 to 1.2% by country. In 2017 around 46 million people in the world had bipolar disorder, with 52% and 48% being female and male, respectively. The typical age of onset is the late teens or the early 20s, and a history of depression is common in people diagnosed with bipolar disorder. However, the high cost associated with the treatment of these mental issues is expected to hamper the market growth.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Application
o By Drug Classification
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape: Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Antipsychotic Drugs Market Report by Segment
By Application
- Dementia
- Bipolar Disorder
- Schizophrenia
- Dementia
- Others
By Drug Classification
- First Generation (Typical)
- Second Generation (Atypical)
A full report of Antipsychotic Drugs Market is available at: https://www.omrglobal.com/industry-reports/antipsychotic-drugs-market
Antipsychotic Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Eli Lilly & Co.
- AstraZeneca plc
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
